theravance.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /application/attributes Disallow: /application/authentication Disallow: /application/bootstrap Disallow: /application/config Disallow: /application/controllers Disallow: /application/elements Disallow: /application/helpers Disallow: /application/jobs Disallow: /application/languages Disallow: /application/mail Disallow: /application/models Disallow: /application/page_types Disallow: /application/single_pages Disallow: /application/tools Disallow: | ||
Meta Tags
| Title | Home | Theravance Biopharma, |
| Description | Targeting What Matters Theravance Biopharma aims to transform the treatment of serious diseases through the discovery and development of organ-selective medicines. Learn |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 35.190.22.133 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
theravance.com Valuation
|
US$20,346,447
Last updated: 2023-05-01 07:06:55
theravance.com has Semrush global rank of 520,204. theravance.com has an estimated worth of US$ 20,346,447, based on its estimated Ads revenue. theravance.com receives approximately 2,347,667 unique visitors each day. Its web server is located in United States, with IP address 35.190.22.133. According to SiteAdvisor, theravance.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$20,346,447 |
| Daily Ads Revenue | US$18,782 |
| Monthly Ads Revenue | US$563,441 |
| Yearly Ads Revenue | US$6,761,281 |
| Daily Unique Visitors | 156,512 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| theravance.com. | A | 3599 | IP: 35.190.22.133 |
| theravance.com. | NS | 600 | NS Record: pdns14.domaincontrol.com. |
| theravance.com. | NS | 600 | NS Record: cbru.br.ns.els-gms.att.net. |
| theravance.com. | NS | 600 | NS Record: cmtu.mt.ns.els-gms.att.net. |
| theravance.com. | NS | 600 | NS Record: pdns13.domaincontrol.com. |
| theravance.com. | MX | 3600 | MX Record: 0 theravance-com.mail.protection.outlook.com. |
| theravance.com. | TXT | 3600 | TXT Record: MS=ms90726515 |
| theravance.com. | TXT | 3600 | TXT Record: docusign=f3c8eb8d-9adf-460c-a95b-e518ab8ddcad |
| theravance.com. | TXT | 3600 | TXT Record: docusign=93967264-b2b7-499b-be46-6091f85a3036 |
| theravance.com. | TXT | 3600 | TXT Record: v=spf1 ip4:216.101.17.201 include:spf.protection.outlook.com include:sp1.theravance.com include:sp2.theravance.com include:sp3.theravance.com ip4:206.188.31.141 -all |
| theravance.com. | TXT | 3600 | TXT Record: BzOAdUdg6dDQ61jYubPrzQs02URrS7mOHXDIAI8S8LDV4mQ3wHBdVNPDBwFNEkq0AnuFRZumTONquJc0+Kg2Tg== |
HtmlToTextCheckTime:2023-05-01 07:06:55
| About Us Our Company Leadership Board of Directors Our Partners Contact Us Our Pipeline Our Product Our Study Join Our Team Our Culture & Values Current Opportunities Investors News Presentations & Events SEC Filings Analyst Coverage Corporate Governance Leadership Board of Directors Committee Composition Email Alerts --> Targeting What Matters Most ™ Theravance Biopharma aims to transform the treatment of specialty respiratory and neurologic diseases through the discovery, development and commercialization of Medicines that Make a Difference ® in patients’ and caregivers’ lives. Our Study Targeting What Matters Most ™ Our research is focused in the areas of inflammation and immunology, and our pipeline of internally discovered programs is targeted to address significant patient needs. Our Pipeline Targeting What Matters Most ™ Theravance Biopharma is a place for collaborators and creative problem-solvers – people who thrive on applying insight and innovation to discovering novel |
HTTP Headers
HTTP/1.1 302 Found Date: Sat, 23 Oct 2021 22:14:56 GMT Server: Apache Location: https://www.theravance.com/ Content-Type: text/html; charset=iso-8859-1 Via: 1.1 google Set-Cookie: GCLB=CPajvfOfx_2AlAE; path=/; HttpOnly; expires=Sat, 23-Oct-2021 23:15:00 GMT Transfer-Encoding: chunked HTTP/2 200 date: Sat, 23 Oct 2021 22:14:56 GMT server: Apache cache-control: max-age=0, private, must-revalidate cache-control: no-cache, private set-cookie: CONCRETE5=e0233dcb9ad200289a8341cf2f411e31; path=/; secure; HttpOnly set-cookie: GCLB=CNH83dXb7LaKag; path=/; HttpOnly; expires=Sat, 23-Oct-2021 23:15:00 GMT x-frame-options: SAMEORIGIN x-xss-protection: 1 x-content-type-options: nosniff access-control-allow-origin: * referrer-policy: strict-origin-when-cross-origin content-type: text/html; charset=UTF-8 via: 1.1 google alt-svc: clear |
theravance.com Whois Information
Domain Name: THERAVANCE.COM Registry Domain ID: 73035689_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2018-10-23T07:31:07Z Creation Date: 2001-06-22T13:19:12Z Registry Expiry Date: 2022-06-22T13:19:12Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: CBRU.BR.NS.ELS-GMS.ATT.NET Name Server: CMTU.MT.NS.ELS-GMS.ATT.NET Name Server: PDNS13.DOMAINCONTROL.COM Name Server: PDNS14.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T07:29:48Z <<< |